Decreasing blood wastage during ex vivo lung perfusion recovery through utilization of thermal control technology.

blood usage blood wastage ex vivo lung perfusion lung transplantation organ care system quality improvement

Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 30 09 2022
accepted: 29 10 2022
pubmed: 10 11 2022
medline: 6 1 2023
entrez: 9 11 2022
Statut: ppublish

Résumé

The Organ Care System (OCS) is a revolutionary ex vivo organ perfusion technology that can potentially expand the organ retrieval range. The OCS Lung device uses packed red blood cells (pRBC) with a proprietary solution. We report the ability to reduce blood waste during this procedure by using a thermal packaging solution in conjunction with the OCS platform. We retrospectively reviewed all OCS Lung recoveries performed by our recovery team, using pRBCfrom May 2019 to January 2021. Initially, units were stored using passive refrigeration with the Performance cooler at a temperature range of 1-6°C for 4 h. Subsequently, thermal control technology with the ProMed cooler was utilized to maintain the same temperature range for 72 h. Twenty-three recoveries were initiated with 63 pRBC. The Performance cooler was used for 8, while the ProMed cooler for 13. 37.5% of pRBC transported with the Performance cooler was used within the validated time range, while 25.0% were used beyond the validated time range based on clinical judgment. In addition, 37.5% of pRBC transported with the Performance cooler were returned to the institution after canceled recoveries with an estimated loss of $1800; the ProMed cooler had no wastage. This study showed that using an advanced thermal packaging solution facilitates proper storage of pRBC and represents an advancement for extended donor lung preservation. The elimination of blood wastage in this initial study portends ongoing benefits for the limited blood supply and reduced cost.

Sections du résumé

BACKGROUND BACKGROUND
The Organ Care System (OCS) is a revolutionary ex vivo organ perfusion technology that can potentially expand the organ retrieval range. The OCS Lung device uses packed red blood cells (pRBC) with a proprietary solution. We report the ability to reduce blood waste during this procedure by using a thermal packaging solution in conjunction with the OCS platform.
METHODS METHODS
We retrospectively reviewed all OCS Lung recoveries performed by our recovery team, using pRBCfrom May 2019 to January 2021. Initially, units were stored using passive refrigeration with the Performance cooler at a temperature range of 1-6°C for 4 h. Subsequently, thermal control technology with the ProMed cooler was utilized to maintain the same temperature range for 72 h.
RESULTS RESULTS
Twenty-three recoveries were initiated with 63 pRBC. The Performance cooler was used for 8, while the ProMed cooler for 13. 37.5% of pRBC transported with the Performance cooler was used within the validated time range, while 25.0% were used beyond the validated time range based on clinical judgment. In addition, 37.5% of pRBC transported with the Performance cooler were returned to the institution after canceled recoveries with an estimated loss of $1800; the ProMed cooler had no wastage.
CONCLUSIONS CONCLUSIONS
This study showed that using an advanced thermal packaging solution facilitates proper storage of pRBC and represents an advancement for extended donor lung preservation. The elimination of blood wastage in this initial study portends ongoing benefits for the limited blood supply and reduced cost.

Identifiants

pubmed: 36349705
doi: 10.1111/jocs.17147
pmc: PMC10099649
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5011-5018

Informations de copyright

© 2022 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals LLC.

Références

BMC Emerg Med. 2020 Jul 7;20(1):55
pubmed: 32635889
Transplantation. 2017 Oct;101(10):2303-2311
pubmed: 28009782
CJEM. 2019 May;21(3):365-373
pubmed: 30404667
N Engl J Med. 2017 Oct 12;377(15):1485-1488
pubmed: 29020590
J Trauma Acute Care Surg. 2017 Jun;82(6S Suppl 1):S70-S78
pubmed: 28333828
J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1971-1981
pubmed: 29449154
Semin Thorac Cardiovasc Surg. 2019 Spring;31(1):1-6
pubmed: 29935227
Eur Respir Rev. 2020 Jul 21;29(157):
pubmed: 32699023
Air Med J. 2017 Nov - Dec;36(6):302-306
pubmed: 29122111
Transfusion. 2021 Jan;61(1):294-302
pubmed: 33206404
J Card Surg. 2022 Dec;37(12):5011-5018
pubmed: 36349705
Transfusion. 2020 Jul;60(7):1470-1475
pubmed: 32445417
Air Med J. 2019 May - Jun;38(3):165-167
pubmed: 31122580
Lancet Respir Med. 2018 May;6(5):357-367
pubmed: 29650408
Lancet Respir Med. 2019 Nov;7(11):975-984
pubmed: 31378427
Curr Opin Organ Transplant. 2020 Jun;25(3):268-273
pubmed: 32332197
Clin Lab Med. 2020 Dec;40(4):587-601
pubmed: 33121624
Transfusion. 2020 May;60(5):908-911
pubmed: 32198754
J Thorac Dis. 2019 Apr;11(4):1635-1650
pubmed: 31179109
Transfusion. 2010 Sep;50(9):1887-96
pubmed: 20456700
Transfusion. 2021 Jul;61 Suppl 1:S286-S293
pubmed: 34269456
ASAIO J. 2018 Mar/Apr;64(2):135-139
pubmed: 28857775
J Thorac Dis. 2019 Sep;11(Suppl 14):S1755-S1760
pubmed: 31632752

Auteurs

Blaine Johnson (B)

Perfusion Services, UChicago Medicine, Chicago, Illinois, USA.

Jamie Bucio (J)

Department of Surgery, Section of Cardiac Surgery, University of Chicago, Chicago, Illinois, USA.

Christopher Salerno (C)

Department of Surgery, Section of Cardiac Surgery, University of Chicago, Chicago, Illinois, USA.

Valluvan Jeevanandam (V)

Department of Surgery, Section of Cardiac Surgery, University of Chicago, Chicago, Illinois, USA.

Tae Song (T)

Department of Surgery, Section of Cardiac Surgery, University of Chicago, Chicago, Illinois, USA.

Geoffrey Wool (G)

Department of Pathology, University of Chicago, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH